Otsuka to Launch QuickNaviTM-Noro3, a Norovirus Antigen Quick Detection Kit

Otsuka Pharmaceutical Co., Ltd. will launch the norovirus antigen test kit QuickNavi™- Noro3 to medical institutions across Japan. It is the latest product in the QuickNaviTM series of in vitro diagnostics. The kit, manufactured domestically by Denka Company Limited, will be co-marketed by the two companies from October 26.

QuickNavi™-Noro3 is an assay kit for rapid and specific detection of norovirus antigen in feces using immunochromatography. There are multiple genotypes of norovirus, and compared to QuickNavi™-Noro 2, this product has improved sensitivity for a wide variety of genotypes, including those that have become prevalent in recent years. As with the conventional product, this kit does not require centrifugation or other pretreatment of specimens, and final determination of the presence or absence of the virus can be made within 15 minutes.

Preview

来源: Otsuka

Preview

来源: Otsuka

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。